Azanza garckeana

Traditional medicine encompasses manual therapies, exercises, and spiritual therapies in addition to medical therapies, theories, and practices that involve medications derived from plants, animals, and minerals. This investigation aims to assess the ability of Azanza garckeana in treating diarrhea in Swiss mice. Castor oil-induced diarrhea and gastrointestinal transit models in mice were used to assess the antidiarrheal effects of various dosages of the plant extract (25, 50, and 100 mg/kg). According to the study’s findings, the extract significantly (p < 0.05) reduced both the frequency of wet feces being defecated and the amount of feces produced overall when compared to the control group. In comparison to the untreated control, the extract triggered a substantial (p < 0.05) antimotility activity at higher doses. In conclusion, this study validated the ethnomedicinal report of Azanza garckeana as an efficacious anti-diarrhoea property, thereby required further study for compound elucidation and evaluation

Arsenic trioxide, widely used in industry and medicine, poses significant risks of cardiotoxicity by inducing oxidative stress, inflammation, and damage to cardiac tissue. Azanza garkeana, a medicinal plant rich in bioactive compounds, exhibits antioxidant and anti-inflammatory properties, offering potential cardioprotective effects by mitigating oxidative damage and preserving cardiac function. The aim of this study was to assess the effect of Azanza garckeana on arsenic trioxide-induced cardiotoxicity in adult Wistar rats. Thirty (30) Wistar rats were randomly divided into six (6) groups of five (5) rats each. Group A served as the control group and receive 1 ml of distilled water. Group B received 100 mg/kg body weight of Arsenic trioxide only. Group C received 100 mg/kg body weight of Arsenic trioxide + 500 mg/kg body weight of Azanza garckeana. Group D received 100mg/kg body weight of Arsenic trioxide + 1000mg/kg body weight of Azanza garckeana. Group E and Group F received 500 mg/kg and 1000 mg/kg body weight of Azanza garckeana only, respectively. Rats received oral administration for 28 days. The rats were sacrificed afterwards and heart tissues were harvested and processed for routine haematoxylin and eosin staining. Results showed some histological alterations: hypertrophic cardiomypathy, vascular dilatation and congestion, perivascular infiltrates of inflammatory cells, evidence of myocarditis in rats treated with arsenic trioxide only. However, there were significant improvements in the rats treated with arsenic trioxide and Azanza garckeana evidenced by normal histological features: branching and anastomosing myocardial fibres with centrally-located nuclei. In conclusion, findings from this study showed that Azanza garckeana protects against arsenic trioxide-induced cardiotoxicity in Wistar rats.

Azanza garckeana , a plant native to Central, Eastern, and Southern Africa, as well as parts of West Africa, is traditionally renowned for its medicinal properties, particularly its role in enhancing male reproductive health. This study investigated the protective effects of aqueous leaf extract of Azanza garckeana (AGE) against lead acetate-induced testicular toxicity in Wistar rats. This specific objectives evaluated the phytochemical constituents and antioxidant capacity of Azanza garckeana , as well as its effects on various physiological and
biochemical parameters in Wistar rats. The objectives also included assessing changes in body and organ weights, oxidative stress markers, and male reproductive hormones (FSH, LH, testosterone) across experimental groups. Additionally, sperm analysis was conducted, and the impact of A. garckeana aqueous extract on the histology of testes in lead acetateinduced rats was examined. Thirty-six adult Wistar rats were divided into six groups. Group A served as the control, receiving only feed and water. Group B was exposed to 100 mg/kg body weight (BW) of lead acetate. Group C received 400 mg/kg BW of AGE only, while Group D was administered 800 mg/kg BW of AGE. Group E received a combination of 400 mg/kg BW of AGE and 100 mg/kg BW of lead acetate, and Group F received 800 mg/kg BW of AGE alongside 100 mg/kg BW of lead acetate.

Azanza garckeana , a plant native to Central, Eastern, and Southern Africa, as well as parts of West Africa, is traditionally renowned for its medicinal properties, particularly its role in enhancing male reproductive health. This study investigated the protective effects of aqueous leaf extract of Azanza garckeana (AGE) against lead acetate-induced testicular toxicity in Wistar rats. This specific objectives evaluated the phytochemical constituents and antioxidant capacity of Azanza garckeana , as well as its effects on various physiological and biochemical parameters in Wistar rats. The objectives also included assessing changes in body and organ weights, oxidative stress markers, and male reproductive hormones (FSH, LH, testosterone) across experimental groups. Additionally, sperm analysis was conducted, and the impact of A. garckeana aqueous extract on the histology of testes in lead acetateinduced rats was examined. Thirty-six adult Wistar rats were divided into six groups. Group A served as the control, receiving only feed and water. Group B was exposed to 100 mg/kg body weight (BW) of lead acetate. Group C received 400 mg/kg BW of AGE only, while Group D was administered 800 mg/kg BW of AGE. Group E received a combination of 400 mg/kg BW of AGE and 100 mg/kg BW of lead acetate, and Group F received 800 mg/kg BW of AGE alongside 100 mg/kg BW of lead acetate. The maceration method was employed to extract the plant’s bioactive components, as it is a simple and effective technique that ensures optimal recovery of phytochemicals while preserving their integrity for analysis